Skip to content

Effect of ETT-BF on pathogenesis of MDRAB-associated VAP and its intervention

Effect of ETT-BF on pathogenesis of MDRAB-associated VAP and its intervention

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17014144
Enrollment
Unknown
Registered
2017-12-25
Start date
2017-12-27
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator-associated pneumonia

Interventions

Case series:Nil

Sponsors

TIanjin First Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with VAP and intubated for more than 72 hours

Exclusion criteria

Exclusion criteria: 1. Patients who had been intubated or re-intubated before admission or those intubated less than 72 hours 2. Patients who are participating in other related clinical trials

Design outcomes

Primary

MeasureTime frame
Resistance gene expression levels;Sensitivity to drugs;

Secondary

MeasureTime frame
Homology;

Countries

China

Contacts

Public ContactGao Hongmei

TIanjin First Center Hospital

ghm182@163.com+86 022-23626321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026